• FirefoxInstall the new Firefox »
  •  Dow Down0.62% Nasdaq Down0.82%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    7.94 Down 0.31(3.70%) 2:36PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 105,412   45,561   558  
    Cost of Revenue5,224  9,612   -  
    Gross Profit 100,188   35,949   558  
    Operating Expenses
    Research Development120,593  162,900  144,709  
    Selling General and Administrative139,790  146,615  60,909  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (160,195) (273,566) (205,060)
    Income from Continuing Operations
    Total Other Income/Expenses Net6,298   -  (15,613)
    Earnings Before Interest And Taxes(153,897)(273,566)(220,673)
    Interest Expense8,075  153  199  
    Income Before Tax(161,972)(273,719)(220,872)
    Income Tax Expense630  439   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(162,602)(274,158)(220,872)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (162,602) (274,158) (220,872)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (162,602) (274,158) (220,872)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.